欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号IE/V/0221/001
药品名称Ubrolexin
活性成分
    • cefalexin 20.0 mg/g
剂型Intramammary suspension
上市许可持有人Boehringer Ingelheim Vetmedica GmbH Binger Strasse 173 55216 Ingelheim am Rhein Germany
参考成员国 - 产品名称Ireland (IE)
Ubrolexin intramammary suspension for lactating dairy cows
互认成员国 - 产品名称
    • Lithuania (LT)
    • Estonia (EE)
    • Hungary (HU)
    • Cyprus (CY)
    • Czechia (CZ)
    • Romania (RO)
    • Slovakia (SK)
    • Slovenia (SI)
    • Germany (DE)
    • Belgium (BE)
    • Netherlands (NL)
    • Luxembourg (LU)
    • United Kingdom (Northern Ireland) (XI)
    • Austria (AT)
    • France (FR)
    • Spain (ES)
    • Portugal (PT)
    • Italy (IT)
    • Greece (GR)
    • Poland (PL)
    • Latvia (LV)
许可日期2008/07/02
最近更新日期2022/09/21
药物ATC编码
    • QJ ANTIINFECTIVES FOR SYSTEMIC USE
申请类型
  • TypeLevel1：[not specified]
  • TypeLevel2：[not specified]
  • TypeLevel3：Bibliographic (well established use) -art 13 (a) Dir 2001/82/EC
  • TypeLevel4：[not specified]
  • TypeLevel5：[not specified]
附件文件下载
    市场状态Positive
    ©2006-2024 Drugfuture->European Union HMA Authorisation of Medicines DataBase